Medical News

---

• Reduced brain activation during response inhibition in BD
• Genetic syndrome increases negative symptoms in teens at psychosis risk
• Cutting thrombolysis delays key to reducing stroke disability
• Echo improves rheumatic heart disease detection in Africa
• Marathon mortality remains low despite increased participation
• New diabetes monotherapy shows promise
• Fluorescent liver imaging guides pancreatic cancer surgery
• Fluorescent liver imaging guides pancreatic cancer surgery
• Statins may slow prostate enlargement
• ‘Refined’ procedure, experienced surgeons improve prostatectomy outcomes
• Folic acid may reduce some childhood cancers
• School-based asthma interventions may reduce absenteeism
• DEFUSE 2 suggests extended treatment window with MRI mismatch
• ARITS, MASH-2 findings disappoint

Reduced brain activation during response inhibition in BD Posted: 28 May 2012 05:00 PM PDT Euthymic bipolar disorder patients exhibit reduced activation in certain brain regions associated with response inhibition, researchers report.

Genetic syndrome increases negative symptoms in teens at psychosis risk Posted: 28 May 2012 05:00 PM PDT The presence of 22q11.2 deletion syndrome in adolescent patients at ultra-high risk for psychosis is associated with more severe negative symptoms and poorer functioning, study results show.

Cutting thrombolysis delays key to reducing stroke disability Posted: 28 May 2012 05:00 PM PDT Cutting delays to stroke thrombolysis has a far greater impact on poststroke disability than does extending the treatment window or the licensing indications, say researchers.

Echo improves rheumatic heart disease detection in Africa Posted: 27 May 2012 05:00 PM PDT Researchers report that adding echocardiography to standard rheumatic heart disease-screening protocols may increase the frequency with which the condition is detected in endemic regions of the world, such as sub-Saharan Africa.

Marathon mortality remains low despite increased participation Posted: 27 May 2012 05:00 PM PDT The number of people who die after completing a marathon remains low even though participation has increased almost twofold since 2000, say researchers.

New diabetes monotherapy shows promise Posted: 27 May 2012 05:00 PM PDT Imeglimin appears to be a well-tolerated and effective monotherapy for Type 2 diabetes, report researchers.

Fluorescent liver imaging guides pancreatic cancer surgery Posted: 27 May 2012 05:00 PM PDT Realtime near-infrared camera imaging can detect hepatic micrometastases in patients with pancreatic cancer before they are visible radiographically, research shows.

Fluorescent liver imaging guides pancreatic cancer surgery Posted: 27 May 2012 05:00 PM PDT Realtime near-infrared camera imaging can detect hepatic micrometastases in patients with pancreatic cancer before they are visible radiographically, research shows.

Statins may slow prostate enlargement Posted: 27 May 2012 05:00 PM PDT Taking statins may slow prostate growth in men with raised prostate-specific antigen levels, report researchers.

‘Refined’ procedure, experienced surgeons improve prostatectomy outcomes Posted: 27 May 2012 05:00 PM PDT Postoperative erectile function can be recovered in robotic-assisted radical prostatectomy patients if they are treated by experienced surgeons who use a nerve-sparing approach, say researchers.

Folic acid may reduce some childhood cancers Posted: 27 May 2012 05:00 PM PDT Rates of two childhood cancers that are thought to originate in utero have fallen significantly since the introduction of mandatory fortification of grain-enriched products with folic acid, US study data show.

School-based asthma interventions may reduce absenteeism Posted: 27 May 2012 05:00 PM PDT Children who attend schools in the most deprived areas are more likely to report absences because of asthma than those who attend schools in wealthier areas, US researchers report.

DEFUSE 2 suggests extended treatment window with MRI mismatch Posted: 27 May 2012 05:00 PM PDT Patients with stroke who have salvageable tissue on magnetic resonance imaging benefit from endovascular therapy even late after symptom onset, say the DEFUSE 2 investigators.

ARITS, MASH-2 findings disappoint Posted: 27 May 2012 05:00 PM PDT The ARTIS and MASH-2 trials have reported negative results, with disappointment for aspirin treatment during stroke thrombolysis and for magnesium treatment in patients with subarachnoid hemorrhage.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610